肌电生物反馈治疗在脑梗死偏瘫患者中疗效观察.docVIP

肌电生物反馈治疗在脑梗死偏瘫患者中疗效观察 　　[摘要] 目的 研究肌电生物反馈治疗在脑梗死偏瘫患者中的临床疗效。 方法 选取我院2011年11月～2012年10月的106例急性脑梗死偏瘫患者，平均（63.15±10.63）岁。其中男66例，平均（60.64±11.41）岁；女40例，平均（67.24±10.63）岁。所有患者的心脑血管疾病病程1～15年，采用疗效对比实验的方法，按照1∶1的人数比例将患者分为实验组和对照组，实验组病患在给予药物治疗的基础上增加肌电生物反馈治疗，对照组患者仅给予常规药物治疗，实验结束后比较两种疗法的临床效果。 结果 治疗前两组肌电值比较无明显差异（P 0.05）；治疗后两组肌电值比较具有明显的差异（P 0.05）；治疗后两组NIHSS评分比较具有显著的差异（P 0.05）；治疗后两组ADL评分比较具有显著的差异（P 　　[关键词] 肌电生物反馈治疗；脑梗死偏瘫；临床疗效 　　[中图分类号] R743.3 [文献标识码] B [文章编号] 1673-9701（2013）25-0135-03 　　Effect of treatment by EMG biofeedback in patients with cerebral infarction 　　WANG Ling1 ZHANG Yunling2 　　1.Department of Neurology， Jinhua Central Hospital in Zhejiang Province， Jinhua 321000， China； 2.Department of Encephalopathy， Beijing University of Chinese Medicine Oriental Hospital， Beijing 100078， China 　　[Abstract] Objective To study the EMG biofeedback therapy in stroke patients with hemiplegic in clinical efficacy. Methods Our hospital from November 2011 to October 2012， 106 patients with acute cerebral hemiplegic patient， patients age distribution range of 48 to 79 years， mean age （63.15±10.63） years of age. Including 66 males， mean age （60.64±11.41） years； 40 females， mean age （67.24±10.63） years of age. All patients with cardiovascular disease during the course of the disease ranged from 1 to 15 years， using the comparative efficacy of experimental methods， in accordance with the proportion of 1：1 were divided into experimental group and control group， the experimental group had given medical treatment based on added to give EMG biofeedback treatment， the control group of patients treated with conventional therapy only， after the end of experiment compared the clinical effects of differences in both treatments. Results Before treatment， EMG showed no significant difference（P 0.05）， statistically insignificant； Emg compare two groups after treatment with significant differences（P 0.05）， statistically insignificant； after treatment NIHSS score compared with significant differences（